शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
INNOVACAPNSEInnova Captab Limited· Pharmaceuticals & BiotechnologyHighPositive
Announced Fri, 23 Jan, 2026 · 13:14 IST

Innova Captab declares Rs 2 interim dividend, Q3 profit rises 23%

INNOVACAP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+2.9%Reaction day
₹651.30
prior close
₹740.00
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-2.1%+5.0% vs market
Pharmaceuticals peers, median of 155sector-1.5%+4.4% vs sector

On the reaction day the stock moved 5.0 pts more than Nifty Microcap 250 and 4.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.7
10m
+1.2
15m
-2.6
30m
-2.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+2.9-2.1+5.0-1.5+4.4
Next day
+6.3-2.0+8.3-2.1+8.4
2d
+6.9-0.0+7.0-1.0+7.9
3d
+3.2-0.4+3.6-1.4+4.6
4d
+5.3+1.4+3.9-1.1+6.4
5d
+5.8+0.1+5.7-1.4+7.1
1w
+9.8+5.2+4.6+1.4+8.4
15d
+3.3+3.7-0.3+0.0+3.3
1m
+5.9+3.5+2.4+0.3+5.7
2m
+3.3-9.4+12.7-9.9+13.3
3m
+11.3+9.0+2.3+2.5+8.8
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 155Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board declared an interim dividend of Rs 2 per share (20% on face value Rs 10) for FY 2025-26 with record date January 30, 2026. Q3 FY26 consolidated revenue grew 42% YoY to Rs 450.29 crore, profit after tax rose 23% to Rs 42.15 crore versus Rs 34.20 crore last year. Nine-month consolidated revenue stood at Rs 1,182.22 crore with PAT at Rs 102.83 crore. Consolidated EPS for Q3 was Rs 7.37 versus Rs 5.97 YoY. Standalone Q3 PAT was Rs 27.90 crore.

Likely market impact

Eligible shareholders to receive Rs 2 per share interim dividend. Strong revenue growth signals business momentum, likely positive for sentiment.